Dunvegan Associates’s Humana HUM Stock Holding History

Dunvegan Associates’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$102K	Hold	570	–	–	0.12%	69
2015 Q3	$103K	Hold	570	–	–	0.12%	68
2015 Q2	$109K	Hold	570	–	–	0.12%	64
2015 Q1	$101K	Hold	570	–	–	0.09%	86
2014 Q4	$82K	Hold	570	–	–	0.07%	87
2014 Q3	$74K	Hold	570	–	–	0.07%	85
2014 Q2	$73K	Hold	570	–	–	0.06%	90
2014 Q1	$64K	Buy	+570	New	+$59.4K	0.05%	90

Other funds holding HUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ACPU

Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return

Dunvegan Associates's HUM Position: Q4 2015 in Review

Dunvegan Associates held its Humana (HUM) position steady in Q4 2015 at 570 shares worth $102K. The position accounts for 0.12% of the portfolio, ranked #69.

Dunvegan Associates first reported a position in HUM in Q1 2014 and has held it in 8 quarters since. The position peaked at $109K in Q2 2015. 566 funds tracked by Wall St. Rank hold HUM as of Q4 2015.

Dunvegan Associates held 570 shares of Humana worth $102K as of Q4 2015.
Dunvegan Associates left its Humana share count unchanged in Q4 2015.
Humana made up 0.12% of Dunvegan Associates's portfolio in Q4 2015, its #69 holding.
Dunvegan Associates first reported a position in Humana in Q1 2014 and has held it in 8 quarters since.
Dunvegan Associates's Humana position peaked at $109K in Q2 2015.
566 funds tracked by Wall St. Rank held Humana as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.